Votes: NY A09535 | 2023-2024 | General Assembly

Bill Title: Establishes a generic drug research and development laboratory and production facility to manufacture generic prescription drugs in the state and the empire state biosimilar insulin initiative, which will develop generic forms of the three most widely used forms of insulin.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-03-20 - referred to health [A09535 Detail]

Text: Latest bill text (Introduced) [HTML]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
No roll call record information currently on file.
States not producing parsable votes may be available as images in Supplemental Documents.

Social Comments on NY A09535

feedback